Ontex Group (ONTEX) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
29 Apr, 2026Executive summary
Q1 2026 revenue declined 4% like-for-like year-over-year to €426.3 million, mainly due to weaker demand in baby and feminine care and lower contract manufacturing sales, partially offset by growth in adult care.
Adjusted EBITDA margin fell to 9.1%, down 2.2 percentage points year-over-year, but remained stable quarter-on-quarter.
Adult care, the largest category, continued to grow 2% year-over-year, outperforming softer baby and feminine care markets.
Net financial debt reduced by 5% over the quarter to €550 million, with liquidity position improved to €262 million.
Strategic review and comprehensive action plan underway, including cost improvements and portfolio optimization.
Financial highlights
Revenue for Q1 2026 was €426.3 million, a 4% like-for-like decrease year-over-year and 2.4% lower than Q4 2025.
Adjusted EBITDA was €38.6 million, down 24% year-over-year, with margin at 9.1%.
Operating profit dropped to €15 million from €28.9 million, reflecting lower EBITDA and €3 million in restructuring costs and impairments.
Net financial debt reduced from €577 million to €550 million during the quarter.
Liquidity position improved to €262 million.
Outlook and guidance
Full-year outlook maintained, expecting adjusted EBITDA to increase by 10% with gradual sequential improvement.
Free cash flow expected to turn positive, supported by EBITDA growth and lower capital expenditure.
Leverage ratio targeted to fall below 3x by year-end, from 3.36x at Q1 end.
Stable revenue expected for the full year, with confidence in higher Q2 sales in North America.
Latest events from Ontex Group
- Revenue and EBITDA fell in 2025, but debt reduction and 2026 recovery targets are in place.ONTEX
Q4 202512 Feb 2026 - Strong H1 2024 results and raised outlook as volume growth and cost savings boost profitability.ONTEX
Q2 20242 Feb 2026 - Q3 delivered 29% EBITDA growth, margin gains, and key transformation milestones, with guidance confirmed.ONTEX
Q3 202418 Jan 2026 - Strong volume-driven growth, margin expansion, and lower leverage set the stage for 2025.ONTEX
Q4 202414 Dec 2025 - Q1 2025 margin resilience and strategic actions support a positive 2025 growth outlook.ONTEX
Q1 202528 Nov 2025 - H1 2025 saw revenue and margin declines, but divestments reduced net debt and H2 recovery is expected.ONTEX
Q2 202516 Nov 2025 - H1 2025 saw a 4% revenue and 22% EBITDA drop, but H2 recovery is expected.ONTEX
Q2 2025 TU16 Nov 2025 - Q3 revenue and margin improved sequentially, with guidance and leverage targets reaffirmed.ONTEX
Q3 20254 Nov 2025